BeStock  
Stocks › Biotechnology › GHRS

GH Research GHRS

US equityMarket cap rank #3039Biotechnology
$17.53 −$1.03 (-5.55%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $17.53 0.00%
Open$18.32
Prev close$18.56
Day range$17.29 – $18.32
Volume299.5K
Market cap$1.20B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$19.45M-32.4% YoY
Net profit-$15.15M-63.1% YoY
Diluted EPS-$0.23-53.3% YoY
Free cash flow-$15.04M-66.6% YoY
Operating cash flow-$15.02M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-12.1MSep '24$-8.8MDec '24$-10.8MMar '25$-9.3MJun '25$-14.0MSep '25$-14.1MDec '25$-19.0MMar '26$-15.1MJun '26

Diluted EPS by quarter

-0.23Sep '24-0.17Dec '24-0.19Mar '25-0.15Jun '25-0.23Sep '25-0.23Dec '25-0.31Mar '26-0.23Jun '26

Free cash flow by quarter

$-12.3MSep '24$-10.5MDec '24$-8.6MMar '25$-9.0MJun '25$-13.7MSep '25$-12.3MDec '25$-10.7MMar '26$-15.0MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-18.8%
Return on assets-18.2%
Return on invested capital-19.8%
Current ratio28.70
Liabilities / assets3.5%
Cash & investments$362.65M
Total debt$6,000.00
Net cash (debt)$362.64M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $19.45M $18.75M $60.68M $16.70M $16.54M
Selling and Admin Expenses $7.06M $6.37M $21.65M $5.25M $5.92M
-General & Admin Expense $7.06M $6.37M $21.65M $5.25M $5.92M
Research & Development $12.40M $12.38M $38.77M $11.39M $10.57M
Asset Impairment Loss -$7,000.00 -$1,000.00 -$42,000.00 -$18,000.00 -$30,000.00
Operating Profit -$19.45M -$18.75M -$60.68M -$16.70M -$16.54M
Net Non-Operating Interest Income (Expense) $966,000.00 $582,000.00 $4.62M $722,000.00 $980,000.00
Non-Operating Interest Income $1.05M $666,000.00 $5.08M $812,000.00 $1.00M
Non-Operating Interest Expense $6,000.00 $6,000.00 $35,000.00 $8,000.00 $8,000.00
Total Other Finance Costs $77,000.00 $78,000.00 $428,000.00 $82,000.00 $13,000.00
Other Income (Expense) $3.34M -$801,000.00 $7.80M $1.84M $1.54M
Gain on Sale of Security $3.34M -$801,000.00 $7.80M $1.84M $1.54M
Pretax Profit -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Profit from Continuing Operations -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Net Income to Parent Company -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Net Income to Common Stockholders -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Basic EPS -$0.23 -$0.31 -$0.79 -$0.23 -$0.23
Diluted EPS -$0.23 -$0.31 -$0.79 -$0.23 -$0.23
Depreciation & Amortization & Depletion – – $302,000.00 $78,000.00 $79,000.00
-Depreciation & Amortization – – $302,000.00 $78,000.00 $79,000.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $372.35M $275.27M $288.23M $288.23M $302.02M
Total Current Assets $368.82M $272.23M $285.98M $285.98M $294.79M
Cash and Cash Equivalents & Short-Term Investments $362.65M $267.33M $280.71M $280.71M $288.51M
-Cash and Cash Equivalents $345.05M $242.65M $246.25M $246.25M $249.65M
-Short Term Investments $17.60M $24.67M $34.46M $34.46M $38.85M
Other Current Assets $6.17M $4.91M – – $6.28M
Total Non-Current Assets $3.53M $3.04M $2.25M $2.25M $7.23M
Net PPE $502,000.00 $580,000.00 $620,000.00 $620,000.00 $692,000.00
Other Non-Current Assets $3.02M $2.46M – – –
Total Liabilities $12.86M $11.89M $8.53M $8.53M $10.63M
Total Current Liabilities $12.85M $11.82M $8.38M $8.38M $10.41M
Payables $5.93M $5.21M $4.27M $4.27M $3.84M
-Accounts Payable $5.93M $5.21M $3.77M $3.77M $3.84M
Short-Term Debt and Capital Lease Obligation $354,000.00 $357,000.00 $365,000.00 $365,000.00 $365,000.00
-Current Capital Lease Obligation $354,000.00 $357,000.00 $365,000.00 $365,000.00 $365,000.00
Other Current Liabilities $6.57M $6.25M $407,000.00 $407,000.00 $6.21M
Total Non-Current Liabilities $6,000.00 $75,000.00 $147,000.00 $147,000.00 $217,000.00
Long Term Debt and Capital Lease Obligation $6,000.00 $75,000.00 $147,000.00 $147,000.00 $217,000.00
-Long Term Capital Lease Obligation $6,000.00 $75,000.00 $147,000.00 $147,000.00 $217,000.00
Total Equity $359.49M $263.38M $279.70M $279.70M $291.40M
Stockholders' Equity $359.49M $263.38M $279.70M $279.70M $291.40M
Capital Stock $1.72M $1.55M $1.55M $1.55M $1.55M
-Common Stock $1.72M $1.55M $1.55M $1.55M $1.55M
Additional Paid-In Capital $542.67M $431.13M $431.06M $431.06M $431.06M
Retained Earnings -$187.84M -$173.23M -$154.43M -$154.43M -$140.29M
Gains/Losses Not Affecting Retained Earnings $2.94M $3.92M $1.52M $1.52M -$927,000.00
Receivables – – $1.30M $1.30M –
-Taxes Receivable – – $137,000.00 $137,000.00 –
-Other Receivables – – $1.16M $1.16M –
Prepaid Assets – – $3.97M $3.97M –
-Gross PPE – – $1.68M $1.68M –
-Accumulated Depreciation – – -$1.06M -$1.06M –
Investments and Advances – – $0.00 $0.00 $5.38M
Non Current Accounts Receivables – – $1.63M $1.63M $1.16M
-Other Payable – – $495,000.00 $495,000.00 –
Current Accrued Expenses – – $3.34M $3.34M –
-Available for Sale Securities – – – – $5.38M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$15.02M -$10.67M -$43.55M -$12.33M -$13.68M
Net cash flow from continuing operations -$15.02M -$10.67M -$43.55M -$12.33M -$13.68M
Net Income from Continuing Operations -$15.15M -$18.97M -$48.26M -$14.14M -$14.02M
Gain/Loss from Continuing Operations -$1.73M $2.33M -$1.75M -$140,000.00 $247,000.00
Depreciation & Depletion & Amortization $91,000.00 $91,000.00 $335,000.00 $88,000.00 $89,000.00
Other Non-Cash Items -$2.57M -$2.11M -$10.67M -$2.42M -$2.76M
Change in Working Capital -$845,000.00 $2.96M -$3.09M -$1.56M -$2.90M
Net cash flow from investing $6.34M $8.64M $46.17M $8.84M $9.78M
Net Cash Flow from Continuing Investing Activities $6.34M $8.64M $46.17M $8.84M $9.78M
Net PPE Purchase and Sale -$17,000.00 -$63,000.00 -$121,000.00 -$19,000.00 -$39,000.00
Net Investment Purchase and Sale $6.36M $8.70M $46.29M $8.86M $9.82M
Financing Cash Flow $111.87M $2,000.00 $139.65M -$68,000.00 -$66,000.00
Net Cash Flow from Continuing Financing Activities $111.87M $2,000.00 $139.65M -$68,000.00 -$66,000.00
Net Issuance Payments Of Debt -$71,000.00 -$70,000.00 -$197,000.00 -$68,000.00 -$66,000.00
Net Common Stock Issuance $117.97M $72,000.00 $150.00M $0.00 $0.00
Ending Cash Balance $345.05M $242.65M $246.25M $246.25M $249.65M
Net Change in Cash $103.19M -$2.03M $142.27M -$3.56M -$3.96M
Beginning Cash Balance $242.65M $246.25M $100.79M $249.65M $253.87M
Effect of Exchange Rate Changes -$789,000.00 -$1.57M $3.19M $155,000.00 -$255,000.00
Free Cash Flow -$15.04M -$10.73M -$43.67M -$12.35M -$13.72M
Net Other Financing Charges – – -$10.15M $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on GHRS.

Sign in to join the discussion.

Scroll to Top